These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 12200630

  • 1. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.
    Mizuguchi M, Yamanouchi H, Becker LE, Itoh M, Takashima S.
    Acta Neuropathol; 2002 Oct; 104(4):418-24. PubMed ID: 12200630
    [Abstract] [Full Text] [Related]

  • 2. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K, Lucassen PJ, Spliet WG, Vreugdenhil E, van Rijen PC, Troost D, Jansen FE, Aronica E.
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [Abstract] [Full Text] [Related]

  • 3. Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B).
    Englund C, Folkerth RD, Born D, Lacy JM, Hevner RF.
    Acta Neuropathol; 2005 May; 109(5):519-33. PubMed ID: 15877232
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.
    Wenzel HJ, Patel LS, Robbins CA, Emmi A, Yeung RS, Schwartzkroin PA.
    Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103
    [Abstract] [Full Text] [Related]

  • 6. Cortical neuronal densities and lamination in focal cortical dysplasia.
    Thom M, Martinian L, Sen A, Cross JH, Harding BN, Sisodiya SM.
    Acta Neuropathol; 2005 Oct; 110(4):383-92. PubMed ID: 16151726
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs).
    Sugiura C, Miyata H, Ueda M, Ohama E, Vinters HV, Ohno K.
    Neuropathology; 2008 Aug; 28(4):372-81. PubMed ID: 18179408
    [Abstract] [Full Text] [Related]

  • 10. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Shu HF, Zhang CQ, Yin Q, An N, Liu SY, Yang H.
    J Neuropathol Exp Neurol; 2010 Aug; 69(8):838-49. PubMed ID: 20613633
    [Abstract] [Full Text] [Related]

  • 11. CD34-immunoreactive balloon cells in cortical malformations.
    Fauser S, Becker A, Schulze-Bonhage A, Hildebrandt M, Tuxhorn I, Pannek HW, Lahl R, Schramm J, Blümcke I.
    Acta Neuropathol; 2004 Oct; 108(4):272-8. PubMed ID: 15221338
    [Abstract] [Full Text] [Related]

  • 12. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Li S, Yu S, Zhang C, Shu H, Liu S, An N, Yang M, Yin Q, Yang H.
    Brain Res; 2012 May 09; 1453():46-55. PubMed ID: 22459050
    [Abstract] [Full Text] [Related]

  • 13. Mcm2 labelling of balloon cells in focal cortical dysplasia.
    Thom M, Martinian L, Sisodiya SM, Cross JH, Williams G, Stoeber K, Harkness W, Harding BN.
    Neuropathol Appl Neurobiol; 2005 Dec 09; 31(6):580-8. PubMed ID: 16281906
    [Abstract] [Full Text] [Related]

  • 14. Expression and cellular distribution of high- and low-affinity neurotrophin receptors in malformations of cortical development.
    Aronica E, Ozbas-Gerçeker F, Redeker S, Ramkema M, Spliet WG, van Rijen PC, Leenstra S, Gorter JA, Troost D.
    Acta Neuropathol; 2004 Nov 09; 108(5):422-34. PubMed ID: 15375667
    [Abstract] [Full Text] [Related]

  • 15. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.
    Miyata H, Chiang AC, Vinters HV.
    Ann Neurol; 2004 Oct 09; 56(4):510-9. PubMed ID: 15455398
    [Abstract] [Full Text] [Related]

  • 16. Differential expression patterns of chloride transporters, Na+-K+-2Cl--cotransporter and K+-Cl--cotransporter, in epilepsy-associated malformations of cortical development.
    Aronica E, Boer K, Redeker S, Spliet WG, van Rijen PC, Troost D, Gorter JA.
    Neuroscience; 2007 Mar 02; 145(1):185-96. PubMed ID: 17207578
    [Abstract] [Full Text] [Related]

  • 17. Cajal-Retzius cells, inhibitory interneuronal populations and neuropeptide Y expression in focal cortical dysplasia and microdysgenesis.
    Thom M, Harding BN, Lin WR, Martinian L, Cross H, Sisodiya SM.
    Acta Neuropathol; 2003 Jun 02; 105(6):561-9. PubMed ID: 12734663
    [Abstract] [Full Text] [Related]

  • 18. Transcription of intermediate filament genes is enhanced in focal cortical dysplasia.
    Taylor JP, Sater R, French J, Baltuch G, Crino PB.
    Acta Neuropathol; 2001 Aug 02; 102(2):141-8. PubMed ID: 11563628
    [Abstract] [Full Text] [Related]

  • 19. mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
    Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhann G, Aronica E, Crino PB.
    Ann Neurol; 2004 Oct 02; 56(4):478-87. PubMed ID: 15455405
    [Abstract] [Full Text] [Related]

  • 20. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
    Ying Z, Gonzalez-Martinez J, Tilelli C, Bingaman W, Najm I.
    Epilepsia; 2005 Nov 02; 46(11):1716-23. PubMed ID: 16302851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.